Research Article

Atorvastatin Improves Hepatic Lipid Metabolism and Protects Renal Damage in Adenine-Induced Chronic Kidney Disease in Sprague-Dawley Rats

Figure 2

Effects of atorvastatin on protein expression of lipase and VLDL receptor in various tissues of adenine-induced CKD rats. Lipase expression in (a) liver, (b) skeletal muscle, (c) heart, and (d) adipose tissue and VLDL receptor expression in (e) skeletal muscle, (f) heart, and (g) adipose tissue as determined by western blot analysis in liver of rats treated for 24 days either with normal diet (control) or adenine-supplemented diet (CKD) alone or with atorvastatin (CKD + ATV). Relative optical density was calculated relative to β-actin used as internal control. Each bar represents the mean ± SEM of 5–6 rats. Significant difference from control: . Significant difference from CKD: . SM, skeletal muscle; AT, adipose tissue; HL, hepatic lipase; LPL, lipoprotein lipase.
(a)
(b)
(c)
(d)
(e)
(f)
(g)